Ambalal Sarabhai Enterprises’ arm’s JV obtains regulatory clearance for 5 tests to be manufactured from India

03 Dec 2019 Evaluate

CoSara Diagnostics, a joint venture company of Co-Diagnostics Inc, USA and a Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises, has obtained regulatory clearance for five tests to be manufactured and sold as in vitro diagnostics (IVDs) from their facility in Ranoli India.

The test for Mycobacterium tuberculosis, malaria, hepatitis B, hepatitis C and human papillomavirus (HPV) meet the requirements of the Central Drug Standard Control Organization (CDSCO) Medical Device Rules (MDR), 2017.

Regulatory clearance allows CoSara for the first time to manufacture and sell the test for the detection of the respective pathogens and microorganisms.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

53.77 7.36 (15.86%)
03-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1531.05
Dr. Reddys Lab 6428.05
Cipla 1482.30
Zydus Lifesciences 1093.45
Lupin 1637.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.